Overview

Evaluate Safety and Efficacy of ABT-335 in Combination With Simvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to compare the safety and efficacy of fenofibric acid (ABT-335) + simvastatin combination therapy with ABT-335 and simvastatin monotherapy in subjects with multiple abnormal lipid levels in the blood.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Abbott
Treatments:
Simvastatin
Criteria
Inclusion Criteria:

- Subjects with mixed dyslipidemia

- Subjects agree to utilize adequate birth control methods and to adhere to the American
Heart Association (AHA) diet.

Exclusion Criteria:

- Subjects with unstable medical conditions or medical conditions considered
inappropriate in a clinical trial.

- Patients who are taking certain medications or unstable dose of specific medications.

- Women who are pregnant or plan on becoming pregnant, or women who are lactating.